Immunobiology and immunotherapy of COVID‐19: A clinically updated overview

A Esmaeilzadeh, R Elahi - Journal of cellular physiology, 2021 - Wiley Online Library
Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) is a new member of the
coronavirus family that can cause coronavirus disease 2019 (COVID‐19). COVID‐9 has …

Low-dose radiation therapy for benign pathologies

LT Royo, GA Redondo, MÁ Pianetta… - Reports of Practical …, 2020 - journals.viamedica.pl
Radiotherapy (RT) has always been a mainstay for malignant tumors therapy, but it is also
used for benign pathology. The application of low or intermediate doses of RT has been …

Low-dose whole-lung irradiation for COVID-19 pneumonia: short course results

A Ameri, N Rahnama, R Bozorgmehr… - International Journal of …, 2020 - Elsevier
Purpose The COVID-19 outbreak is affecting people worldwide. Many infected patients have
respiratory involvement that may progress to acute respiratory distress syndrome. This pilot …

Low‐dose whole‐lung radiation for COVID‐19 pneumonia: planned day 7 interim analysis of a registered clinical trial

CB Hess, ZS Buchwald, W Stokes, TH Nasti… - Cancer, 2020 - Wiley Online Library
Background Individuals of advanced age with comorbidities face a higher risk of death from
coronavirus disease 2019 (COVID‐19), especially once they are ventilator‐dependent …

Clinically relevant radiation exposure differentially impacts forms of cell death in human cells of the innate and adaptive immune system

SE Falcke, PF Rühle, L Deloch, R Fietkau… - International journal of …, 2018 - mdpi.com
In cancer treatments, especially high-dose radiotherapy (HDRT) is applied. Patients
suffering from chronic inflammatory diseases benefit from low-dose radiation therapy …

Immunomodulatory low-dose whole-lung radiation for patients with coronavirus disease 2019-related pneumonia

CB Hess, TH Nasti, VR Dhere, TJ Kleber… - International Journal of …, 2021 - Elsevier
Purpose Phase 1 clinical trials have established low-dose, whole-lung radiation therapy (LD-
RT) as safe for patients with coronavirus disease 2019 (COVID-19)-related pneumonia. By …

[HTML][HTML] Low dose lung radiotherapy for COVID-19 pneumonia. The rationale for a cost-effective anti-inflammatory treatment

PC Lara, J Burgos, D Macias - Clinical and translational radiation oncology, 2020 - Elsevier
The COVID-19 pandemia is affecting people worldwide. Most of the patients suffered of a
respiratory disease that will progress to an acute respiratory distress syndrome (ARDS) …

New insights into the treatment of meningoencephalomyelitis of unknown origin since 2009: a review of 671 cases

N Jeffery, N Granger - Frontiers in Veterinary Science, 2023 - frontiersin.org
“Meningoencephalomyelitis of unknown origin”(MUO)—a collective term for a group of
clinically-indistinguishable (but pathologically distinct) autoimmune diseases of the CNS …

Current knowledge on Graves' orbitopathy

K Gontarz-Nowak, M Szychlińska… - Journal of clinical …, 2020 - mdpi.com
(1) Background: Graves' orbitopathy (GO) is an autoimmune inflammation of the orbital
tissues and the most common extra-thyroid symptom of Graves' disease (GD). Mild cases of …

Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR …

M Arenas, M Algara, G De Febrer, C Rubio… - Strahlentherapie und …, 2021 - Springer
Purpose To evaluate the efficacy and safety of lung low-dose radiation therapy (LD-RT) for
pneumonia in patients with coronavirus disease 2019 (COVID-19). Materials and methods …